Jonathan Davies
Labour - Mid Derbyshire
1,878 (4.0%) majority - 2024 General ElectionFirst elected: 4th July 2024
Division Voting information
Debates during the 2024 Parliament
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
Sparring Partners
Lord President of the Council and Leader of the House of Commons
(2 debate interactions)
Parliamentary Under-Secretary (Housing, Communities and Local Government)
(2 debate interactions)
Department Debates
(3 debate contributions)
(3 debate contributions)
(2 debate contributions)
(1 debate contributions)
Legislation Debates
(82 words contributed)
Mid Derbyshire Petitions
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
of 105,553 signatures (0.16%)
of 105,553 signatures (0.16%)
of 45,773 signatures (0.14%)
Latest EDMs signed by Jonathan Davies
Commons initiatives
These initiatives were driven by Jonathan Davies, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Jonathan Davies has not been granted any Urgent Questions
Jonathan Davies has not been granted any Adjournment Debates
Jonathan Davies has not introduced any legislation before Parliament
Jonathan Davies has not co-sponsored any Bills in the current parliamentary sitting
Latest 1 Written Question
(View all written questions)Decisions on the routine availability of licensed medicines for National Health Service patients in England are made on the basis of recommendations by the National Institute for Health and Care Excellence (NICE). NICE plays an important role in ensuring that medicines represent a clinically and cost-effective use of NHS resources before they are routinely funded. The NHS is legally required to fund medicines recommended by NICE, normally within three months of final guidance.
NICE aims wherever possible to issue recommendations on new medicines close to the point of licensing and started its appraisal of the medicine sipavibart for preventing COVID-19 ahead of the Medicines and Healthcare products Regulatory Agency’s decision. NICE’s appraisal process is however currently suspended as the manufacturer, AstraZeneca, has been unable to provide an evidence submission as planned. NICE is currently awaiting notification from AstraZeneca on when it can make a submission and will update stakeholders in due course.
Minister of State (Department of Health and Social Care)